Meta分析：经动脉化疗栓塞联合复方苦参注射液治疗肝细胞癌的疗效
Meta-analysis: therapeutic effect of transcatheter arterial chemoembolization combined with compound kushen injection in hepatocellular carcinoma.
作者信息
Sun Qizhe, Ma Wenli, Gao Yuan, Zheng Wenling, Zhang Bao, Peng Yifei
机构信息
Institute of Genetic Engineering, Southern Medical University, 1838 North Guangzhou Road, Guangzhou City, Guangdong Province, 510515, P.R. China.
出版信息
Afr J Tradit Complement Altern Med. 2011 Dec 29;9(2):178-88. doi: 10.4314/ajtcam.v9i2.1. eCollection 2012.
Abstract
Compound Kushen Injection (CKI) is Sophora Flavescens and Heterosmilacis Japonicae extract. Meta-analysis confirmed that CKI plus transcatheter arterial chemoembolization (TACE) is more superior to TACE alone for unresectable hepatocellular carcinoma (UHCC) patients.
摘要
复方苦参注射液（CKI）是苦参和土茯苓提取物。荟萃分析证实，对于不可切除的肝细胞癌（UHCC）患者，复方苦参注射液联合经动脉化疗栓塞术（TACE）比单纯TACE更具优势。
相似文献
1
Meta-analysis: therapeutic effect of transcatheter arterial chemoembolization combined with compound kushen injection in hepatocellular carcinoma.Meta分析：经动脉化疗栓塞联合复方苦参注射液治疗肝细胞癌的疗效
Afr J Tradit Complement Altern Med. 2011 Dec 29;9(2):178-88. doi: 10.4314/ajtcam.v9i2.1. eCollection 2012.
2
A retrospective controlled analysis of outcomes of using integrated therapy of traditional Chinese and modern medicines for primary liver cancer of middle and late stages.中西医结合治疗中晚期原发性肝癌疗效的回顾性对照分析
J Altern Complement Med. 2006 Dec;12(10):941-2. doi: 10.1089/acm.2006.12.941.
3
Meta-analysis: traditional Chinese medicine for improving immune response in patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.Meta 分析：经导管动脉化疗栓塞术治疗后不可切除的肝细胞癌患者的中药改善免疫反应。
Explore (NY). 2011 Jan-Feb;7(1):37-43. doi: 10.1016/j.explore.2010.10.002.
4
Traditional Chinese medicine plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma.中药联合经动脉化疗栓塞术治疗不可切除肝细胞癌
J Altern Complement Med. 2008 Oct;14(8):1027-42. doi: 10.1089/acm.2008.0060.
5
Compound Kushen injection combined with transarterial chemoembolization for hepatocellular carcinoma: An evidence map and overview of systematic reviews.复方苦参注射液联合肝动脉化疗栓塞治疗肝细胞癌的系统评价概述及证据图谱。
J Ethnopharmacol. 2024 Jan 30;319(Pt 3):117267. doi: 10.1016/j.jep.2023.117267. Epub 2023 Oct 13.
6
[Transcatheter arterial chemoembolization combined with other therapies for the treatment of primary hepatic carcinoma: a review].经动脉化疗栓塞联合其他疗法治疗原发性肝癌：综述
Zhong Xi Yi Jie He Xue Bao. 2008 Apr;6(4):422-6. doi: 10.3736/jcim20080419.
7
Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma.经动脉化疗栓塞联合射频消融与单纯经动脉化疗栓塞治疗肝细胞癌的Meta分析
Oncotarget. 2017 Jan 10;8(2):2960-2970. doi: 10.18632/oncotarget.13813.
8
9
[Combined percutaneous ethanol injection through liver puncture and transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma].经肝穿刺联合经导管肝动脉化疗栓塞术治疗肝细胞癌的经皮乙醇注射治疗
Zhonghua Zhong Liu Za Zhi. 2001 Nov;23(6):490-2.
10
Drug effect analysis of sorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma.索拉非尼联合经动脉化疗栓塞术治疗晚期肝细胞癌的药物疗效分析
Pak J Pharm Sci. 2018 Jul;31(4(Special)):1751-1755.
引用本文的文献
1
Prognostic value of immune-inflammation and nutritional indices in advanced hepatocellular carcinoma patients receiving immunotherapy with compound Kushen injection.免疫炎症和营养指标在接受复方苦参注射液免疫治疗的晚期肝细胞癌患者中的预后价值
World J Gastrointest Oncol. 2025 Jul 15;17(7):106684. doi: 10.4251/wjgo.v17.i7.106684.
2
Unveiling the Mechanism of Compound Ku-Shen Injection in Liver Cancer Treatment through an Ingredient-Target Network Analysis.揭示苦参注射液治疗肝癌的作用机制：基于成分-靶点网络的分析。
Genes (Basel). 2024 Sep 29;15(10):1278. doi: 10.3390/genes15101278.
3
Virtual screening and network pharmacology-based synergistic coagulation mechanism identification of multiple components contained in compound Kushen Injection against hepatocellular carcinoma.基于虚拟筛选和网络药理学的复方苦参注射液多成分抗肝癌协同凝血机制研究
J Ayurveda Integr Med. 2024 Sep-Oct;15(5):101055. doi: 10.1016/j.jaim.2024.101055. Epub 2024 Oct 19.
4
Network pharmacology in combination with bibliometrics analysis on the mechanism of compound Kushen injection in the treatment of radiation pneumonia and lung cancer.网络药理学结合文献计量学分析复方苦参注射液治疗放射性肺炎和肺癌的作用机制。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec;397(12):9789-9809. doi: 10.1007/s00210-024-03238-w. Epub 2024 Jun 25.
5
Focus on T cell exhaustion: new advances in traditional Chinese medicine in infection and cancer.聚焦于T细胞耗竭：中医药在感染与癌症领域的新进展
Chin Med. 2023 Jun 24;18(1):76. doi: 10.1186/s13020-023-00785-x.
6
Compound Kushen injection inhibits EMT of gastric cancer cells via the PI3K/AKT pathway.复方苦参注射液通过 PI3K/AKT 通路抑制胃癌细胞 EMT。
World J Surg Oncol. 2022 May 20;20(1):161. doi: 10.1186/s12957-022-02609-y.
7
An Overview of Systematic Reviews: Complementary Therapies for Cancer Patients.系统评价概述：癌症患者的补充疗法。
Integr Cancer Ther. 2019 Jan-Dec;18:1534735419890029. doi: 10.1177/1534735419890029.
8
Oxymatrine‑mediated maturation of dendritic cells leads to activation of FOXP3+/CD4+ Treg cells and reversal of cisplatin‑resistance in lung cancer cells.氧化苦参碱介导的树突状细胞成熟导致 FOXP3+/CD4+Treg 细胞的激活和肺癌细胞顺铂耐药性的逆转。
Mol Med Rep. 2019 May;19(5):4081-4090. doi: 10.3892/mmr.2019.10064. Epub 2019 Mar 20.
9
Novel Sophoridine Derivatives Bearing Phosphoramide Mustard Moiety Exhibit Potent Antitumor Activities In Vitro and In Vivo.新型槐定碱衍生物含有磷酰胺芥基，具有显著的体内外抗肿瘤活性。
Molecules. 2018 Aug 6;23(8):1960. doi: 10.3390/molecules23081960.
10
Anti-Cervical Cancer Role of Matrine, Oxymatrine and Sophora Flavescens Alkaloid Gels and its Mechanism.苦参碱、氧化苦参碱及苦参总碱凝胶对宫颈癌的抑制作用及其机制
J Cancer. 2018 Apr 6;9(8):1357-1364. doi: 10.7150/jca.22427. eCollection 2018.
本文引用的文献
1
[Clinicel study on treatment of advanced primary liver cancer by Yanshu injection combining with chemotherapy].[榄香烯注射液联合化疗治疗晚期原发性肝癌的临床研究]
Zhongguo Zhong Yao Za Zhi. 2006 Mar;31(6):510-2.
2
Chemoembolization in the management of liver tumors.
Oncologist. 2003;8(5):425-37. doi: 10.1634/theoncologist.8-5-425.
3
Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors.经导管动脉化疗栓塞术作为内分泌肿瘤肝转移的一线治疗方法。
Eur Radiol. 2003 Jan;13(1):136-40. doi: 10.1007/s00330-002-1558-0. Epub 2002 Jul 23.
4
Evaluation of response: new and standard criteria.
Ann Oncol. 2002;13 Suppl 4:127-9. doi: 10.1093/annonc/mdf649.
5
Prognostic prediction and treatment strategy in hepatocellular carcinoma.肝细胞癌的预后预测与治疗策略
Hepatology. 2002 Mar;35(3):519-24. doi: 10.1053/jhep.2002.32089.
6
Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization.
Radiology. 1996 Jan;198(1):33-40. doi: 10.1148/radiology.198.1.8539401.
7
Reporting results of cancer treatment.癌症治疗结果报告。
Cancer. 1981 Jan 1;47(1):207-14. doi: 10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6.
8
Evaluation of patients with advanced cancer using the Karnofsky performance status.使用卡诺夫斯基功能状态评分法对晚期癌症患者进行评估。
Cancer. 1980 Apr 15;45(8):2220-4. doi: 10.1002/1097-0142(19800415)45:8<2220::aid-cncr2820450835>3.0.co;2-q.
9
Chemoembolization for hepatocellular carcinoma.
J Clin Oncol. 1990 Jun;8(6):1108-14. doi: 10.1200/JCO.1990.8.6.1108.
Zotero 插件